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Abstract
Background: CCHCR1 (Coiled-Coil α-Helical Rod protein 1) is a putative psoriasis candidate gene with the risk
alleles CCHCR1*WWCC and *Iso3, the latter inhibiting the translation of isoform 1. CCHCR1 was recently shown to be
a centrosomal protein, as well as a component of cytoplasmic processing bodies (P-bodies) that regulate mRNA
turnover. The function of CCHCR1 has remained unsettled, partly because of the inconsistent findings; it has been
shown to play a wide variety of roles in divergent processes, e.g., cell proliferation and steroidogenesis. Here we
utilized RNA sequencing (RNAseq) using HEK293 cells overexpressing isoforms 1 or 3 (Iso1, Iso3 cells), in
combination with the coding non-risk or risk (*WWCC) haplotype of CCHCR1. Our aim was to study the overall role
of CCHCR1 and the effects of its variants.
Results: The overexpression of CCHCR1 variants in HEK293 cells resulted in cell line-specific expression profiles
though several similarities were observable. Overall the Iso1 and Iso3 cells showed a clear isoform-specific
clustering as two separate groups, and the Non-risk and Risk cells often exhibited opposite effects. The
RNAseq supported a role for CCHCR1 in the centrosomes and P-bodies; the most highlighted pathways
included regulation of cytoskeleton, adherens and tight junctions, mRNA surveillance and RNA transport.
Interestingly, both the RNAseq and immunofluorescent localization revealed variant-specific differences for
CCHCR1 within the P-bodies.
Conclusions: CCHCR1 influenced a wide variety of signaling pathways, which could reflect its active role in
the P-bodies and centrosomes that both are linked to the cytoskeleton; as a centrosomal P-body protein
CCHCR1 may regulate diverse cytoskeleton-mediated functions, such as cell adhesion and -division. The
present findings may explain the previous inconsistent observations about the functions of CCHCR1.
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Background
Psoriasis is a chronic multifactorial dermatological disorder,
characterized by abnormal proliferation and differentiation
of keratinocytes and infiltration of inflammatory cells.
There are several susceptibility gene loci for psoriasis
(PSORS1–15) (based on the Online Mendelian Inheritance
in Man, OMIM); of which PSORS1 (6p21.3) has the stron-
gest risk effect [1]. Diverse psoriasis-associated alleles have
been identified within the region. However, a strong linkage
disequilibrium has made it difficult to distinguish their indi-
vidual effects. Hence, the effector genes in psoriasis within
the 6p21.3 region are currently not fully understood.
CCHCR1 (Coiled-Coil α-Helical Rod protein 1) is a putative
PSORS1 candidate gene among others [2–4], and its
CCHCR1*WWCC allele is associated with psoriasis in sev-
eral populations [2, 3, 5]. WWCC stands for the amino
acids in the psoriasis risk haplotype, whereas in the
non-risk haplotype the corresponding amino acids are
RRGS. We have previously described a novel form of
CCHCR1, isoform 1, where the N-terminal domain is lon-
ger than in isoform 3 [6]. The formation of isoform 1 is
dependent on a SNP (rs3130453) that results in either a
longer open reading frame (allele *Iso1) or a stop codon
(allele *Iso3), enabling only the translation of isoform 3. In
addition, there are two transcription start sites, only one of
them enabling the production of long isoform 1. Notably,
we demonstrated that *Iso3 shows association with psoriasis
(P < 10− 7) [6].
The CCHCR1 protein does not belong to any known
protein family but is predicted to be a rod-like protein,
with an alpha-helical coiled coil structure. Although its
expression pattern in psoriatic skin differs from healthy
skin [7, 8] and its overexpression influences cell prolifer-
ation [6, 9, 10], its role as a putative psoriasis effector
gene has remained unsettled, partially because it has
been suggested to function in several divergent bio-
logical processes such as the regulation of steroidogene-
sis via mitochondrial steroidogenic activator protein
(STAR) [8, 11] or muscle differentiation via RNA poly-
merase II subunit 3 (RPB3) [12]. We have also demon-
strated that in addition to its cytoplasmic location, both
CCHCR1 isoforms localize at the centrosome [6], a cell
organelle playing a crucial role in cell division. The
centrosomal localization of CCHCR1 has been verified
in other large-scale proteomics studies [13, 14].
Furthermore, CCHCR1 has been shown to interact with
mitotic spindle proteins [15], providing evidence for its
possible involvement in cell division. A recent study
demonstrated that, in addition to its location at the
centrosome, CCHCR1 is a component of processing
bodies (P-bodies) [15]. P-bodies are cytoplasmic ribonu-
cleoprotein granules that regulate mRNA turnover in a
post-transcriptional manner and are involved in mRNA
degradation, surveillance, and transport, translational
repression, and RNA-mediated gene silencing [16, 17].
There is a link between the P-bodies and centrosomes;
P-bodies transit along microtubule tracks to and from the
centrosome and furthermore, a pair of stationary P-bodies
reside at the centrosome during the interphase [18, 19].
Using stable HEK293 cells overexpressing isoforms
1 or 3 with the non-risk (*RRGS) or the risk haplo-
type (*WWCC) we have shown that isoform 3 acceler-
ates cell proliferation and together with the *WWCC
allele apoptosis as well. Whereas isoform 1 lacks sig-
nificant effects on cell proliferation or cell cycle pro-
gression. Furthermore, the CCHCR1-HEK293 cell
lines show isoform- and haplotype-specific changes in
cell size and shape and have alterations in the
organization and expression of the cytoskeletal pro-
teins actin, vimentin, and cytokeratins. We also dem-
onstrated that CCHCR1 may regulate EGF-induced
STAT3 activation in an isoform-specific manner [6].
Here we applied 5’end-targeted RNA sequencing (RNA-
seq) on the previously established and characterized
CCHCR1-HEK293 cell lines (Iso1Risk, Iso1Non-risk,
Iso3Risk, and Iso3Non-risk) [6, 20] to examine isoform-
and haplotype-specific effects on global gene expression
profiles, and to identify the underlying mechanisms lead-
ing to the previously observed differences between the
CCHCR1 cell lines. The sensitivity of RNAseq allowed an
in-depth assessment of altered gene expression in the cell
lines, making it possible to get a better understanding of
the effects of CCHCR1 isoforms on the cellular pathways.
Results
CCHCR1-HEK293 cell lines exhibited isoform- and
haplotype-specific gene expression profiles
In the present study we used stably transfected
CCHCR1 cell lines that were previously generated
into human embryonic kidney (HEK) 293 cells. HEK293 is
an adenovirus-transformed cell line that is considered
tumorigenic. The establishment and characterization of
the CCHCR1 overexpressing HEK293 clones have been
described previously [6]. Briefly, the CCHCR1 cell lines
(Iso1Risk, Iso1Non-risk, Iso3Risk, and Iso3Non-risk) were
screened for the CCHCR1 expression by qPCR, fluores-
cence microscopy, and western blotting. The clones used
in the present work were chosen based on the previous
studies; we selected clones with similar CCHCR1 expres-
sion levels and cell morphology. As most of the previous
CCHCR1 studies have focused on isoform 3, we first
performed gene expression profiling using Affymetrix
Human Gene ST 1.0 microarrays for the Iso1Non-risk
and Iso1Risk CCHCR1 cell lines to increase knowledge of
isoform 1. Wild type HEK293 and vector-transfected cells
were used as controls in the comparative expression
analysis. The comparison of Iso1Non-risk and Iso1-
Risk with the vector control revealed 296 and 206
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differentially expressed genes (DEGs) (Cut-off fold
change1.3-fold, p < 0.002), respectively (Additional file 1:
Table S1). Gene enrichment analyses (the Database
for Annotation, Visualization and Integrated Discovery
(DAVID) [21, 22], WebGestalt 2013, and WebGestaltR
2017 [23]) of the DEGs (> 1.5-fold) from the
Iso1Non-risk cells revealed such pathways and func-
tions (p < 1 × 10− 4) as focal adhesion, ECM-receptor
interaction, and regulation of actin cytoskeleton. The
results of the gene enrichment analysis are shown in
detail in Additional file 1: Table S1. Though the
microarray study suggested differences in the gene ex-
pression between Iso1Non-risk and Iso1Risk, the cell
lines sharing only 50 genes, the sensitivity of the ex-
pression profiling remained rather modest. Particularly
in the Iso1Risk cell line only a few pathways, such as
cell cycle, focal adhesion, and leukocyte migration
showed enrichment of more than four genes when
WebGestalt was used. To get a higher sensitivity as-
sessment of altered gene expression in all four
CCHCR1-HEK293 cell lines we performed RNAseq.
RNA samples extracted from the wild type HEK293,
the vector control, and the CCHCR1 cell lines (Iso1-
Non-risk, Iso1Risk, Iso3Non-risk, and Iso3Risk), were
subjected to RNAseq. The comparisons of transcripts
from each CCHCR1-HEK293 cell line with the con-
trols (wild type and vector) revealed a large number
of differentially expressed genes (DEGs) that are listed
in Additional file 2: Table S2. The number of upregu-
lated genes was highest in Iso3Non-risk (6602) and
lowest in Iso3Risk (1781), while the number of down-
regulated genes was highest in Iso3Risk (6968) and
lowest in Iso3Non-risk (2806) (up: FC > 1.5, down:
FC < 0.75, FDR 0.25). All the CCHCR1 cell lines
shared 209 upregulated and 618 downregulated genes
(Venn diagram of DEGs shown in Fig. 1a).
There were notable differences in the expression pro-
files between the CCHCR1-HEK293 cell lines. We esti-
mated the dissimilarity between the cell lines by
principal component analysis (PCA) (Fig. 1b) that en-
abled multiclass comparisons between samples [24]. The
second PC (PC2) depicts the isoform-dependent differ-
ence, clustering isoform 1 (Iso1) and 3 (Iso3) as separate
groups. The wild type and vector control samples clus-
tered as an overlapping group between the Iso1 and Iso3
samples. The PCA demonstrated that the replicates dif-
fered to some extent, especially the Iso3Risk samples
(the outlier specimen 3Rc, Fig. 1b). The clustering of
Risk and Non-risk samples as separate groups was less
clear than observed with Iso1 and Iso3.
Expression profiling of CCHCR1-HEK293 cell lines
highlighted cell adhesion and regulation of cytoskeleton
Using the WebGestalt tool (WebGestalt 2013 and Web-
GestaltR) for gene enrichment analysis, we analyzed the
DEGs of four different comparisons (DEGs shown in
Additional file 2: Table S2: Iso1Non-risk, Iso1Risk,
Iso3Non-risk, and Iso3Risk cells compared with wild
type and vector controls). The KEGG pathway analysis
of up- and downregulated genes revealed several similarities
between the CCHCR1-HEK293 cell lines (Additional file 3:
Table S3 showing the results of gene enrichment analysis).
Adhesion-related pathways, such as focal adhesion, gap
junction, tight junction, adherens junction, and regulation of
Fig. 1 Expression profiles of the CCHCR1-HEK293 cell lines. a Venn diagrams of differentially expressed genes (DEGs) of the CCHCR1-HEK293 cell
lines; Iso1Non-risk (1 N), Iso1Risk (1R), Iso3Non-risk (3 N), and Iso3Risk (3R), when compared with vector and wild type controls (FC > 1.5 or
FC < 0.75, FDR < 0.25). The most highlighted functions and pathways of the gene enrichment analysis of DEGs that were shared by the all four
cell lines are shown. Up- and downregulated genes were analyzed separately (see in detail Additional file 3: Table S3). b Principal component
analysis (PCA) demonstrates differences between CCHCR1-HEK293 cell lines. The two PCs depict the variation between samples. The PC2
illustrates the isoform-dependent difference, clustering isoforms 1 and 3 as separate groups. The wild type (wt) and vector (v) control samples
cluster as an overlapping group between the isoform 1 and isoform 3 samples
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actin cytoskeleton, as well as Wnt signaling and calcium
signaling, were highlighted in all the cell lines. In addition,
MAPK, ErbB, and TGF-beta were among the top
pathways. Their expression profiles, however, showed vari-
ation between the control samples. The most highly up-
and downregulated genes (1 × 108 < FC < 1 × 10− 7) were
enriched especially in functions and pathways that are
involved in neuroactive ligand–receptor interaction, cell
adhesion, calcium signaling, and cytokine-cytokine receptor
interaction (Additional file 3: Table S3).
Although the same pathways were showing enrichment
in all the CCHCR1-HEK293 cell lines, their gene expres-
sion profiles differed; different genes were highlighted, and
the gene expression varied from down- to upregulation
between the cell lines. For example, focal adhesion and
regulation of actin cytoskeleton were the top pathways in
all the lines (Additional file 3: Table S3). However, the cor-
responding heatmaps showed differences between the cell
lines; the Non-risk and Risk cells often exhibited opposite
effects (Fig. 2a showing heatmaps of focal adhesion and
regulation of actin cytoskeleton). Several relevant genes of
focal adhesion and actin cytoskeleton were downregulated
particularly in the Iso3Risk cells. To verify this, we quanti-
fied the expression of TLN1 (talin 1) and FN1 (fibronectin
1) by qPCR (shown in Fig. 2b). They were highly downreg-
ulated in both isoform 3 expressing cell lines (Iso3), espe-
cially in Iso3Risk, whereas their expression was increased
in the Iso1Non-risk cells similarly as was observed in
RNAseq. We also examined the expression of SYT1 (syn-
aptotagmin 1) by qPCR (Fig. 2b); one of the most highly
upregulated genes in the Iso3 cells. The qPCR verified that
its expression was increased only in the Iso3 cells and was
unaltered in both isoform 1 expressing cells (Iso1).
Overall, the qPCR verification results agreed with the
RNAseq data. We have previously shown that our RNA-
seq protocol enables the accurate quantitation of gene ex-
pression [24].
To study the overall biological role of CCHCR1, we
analyzed the DEGs that were shared by the four
CCHCR1-HEK293 cell lines (827 genes, 0.75 > FC > 1.5,
FDR < 0.25). The analyses of shared DEGs (Additional
file 3: Table S3: Intersection up and down) identified
such pathways and genes as: calcium signaling (PLCD1,
PLCB2), NOD-like receptor signaling (NLRP3, CARD9,
and CXCL1), cytokine-cytokine receptor interaction
(IL12A, IL22RA1, and VEGFC), cell adhesion (ITGAL,
CNTN1, and CLDN7), and regulation of actin cytoskeleton
(PAK3, RRAS, and ITGAX), however, the gene counts of
the detected pathways were modest.
Isoform- and haplotype-specific effects of CCHCR1 on cell
signaling
Despite similarities between the CCHCR1-HEK293 cell
lines, some isoform- and haplotype-specific effects on
the gene expression were apparent, which is observable
from the Venn diagram (Fig. 1a) and the heatmaps. For
instance Wnt signaling (heatmap in Fig. 3a) was mainly
upregulated only in the Iso3Non-risk cells when com-
pared with controls (Additional file 3: Table S3). While
several pathways were mainly downregulated in the
Iso3Risk cells, these including regulation of actin cyto-
skeleton (heatmap Fig. 2a) and RIG-I-like receptor signal-
ing (heatmap in Fig. 3b; Additional file 3: Table S3). As
CXCL8 (alias IL8) is involved in several signaling path-
ways that were highlighted in our expression data, as
well as related to psoriasis, we validated its expression in
the CCHCR1-HEK293 cell lines by qPCR; IL8 showed
reduced expression in the Iso3 cell lines and upregula-
tion in the Iso1cells, especially in Iso1Non-risk (Fig. 3c),
as observed in RNAseq.
To study the isoform and haplotype-specific effects of
CCHCR1 more specifically, and to get more statistical
power for the study, we analyzed the DEGs in four dif-
ferent groups; DEGs shared by the Iso1, Iso3, Non-risk,
or Risk cell lines (Fig. 4: the Venn diagram of compari-
sons). The DAVID and WebGestalt (versions 2013 and
2017) analyses revealed differences between the groups
(Additional file 4: Table S4 showing gene enrich analysis
in detail), though the number of gene counts in
highlighted pathways remained modest. Tight junction
was highlighted in the shared DEGs of the Iso1 cells
(FDR = 0.06), progesterone mediated oocyte maturation
in the Iso3 cells (FDR < 0.05), mRNA surveillance
pathway in the Non-risk cells (FDR = 0.02), and antigen
processing and presentation in the Risk cell lines (FDR <
0.05). The gene enrichment analysis of DEGs including
both the up-and downregulated genes that were shared
by all the CCHCR1-HEK293 cell lines (Fig. 4 Venn dia-
gram) highlighted only a few pathways with FDR < 0.1
when analysed by WebGestaltR, these including calcium-
and estrogen signaling (FDR = 0.05). WebGestalt highlighted
cytokine-cytokine receptor interaction, NOD-like receptor
signaling, and adherens junction as well.
As the Iso1 and Iso3 cell lines showed a clear
isoform-specific clustering in the PCA (Fig. 1b), we pooled
the Iso1Non-risk and Risk samples and compared with
the pooled vector and wildtype data (comb_Iso1), and
similarly we pooled and compared Iso3Non-risk and Risk
vs vector and wildtype (comb_Iso3) to increase the num-
ber of replicates and to get more statistical power for the
study. The DEGs were re-extracted by a two class un-
paired comparison using a higher permutation (n = 1000).
(Additional file 5: Table S5 showing the DEGs and the re-
sults of gene enrichment analysis for comb_Iso1 and com-
b_iso3). We also pooled the data from Iso1Non-risk and
Iso3Non-risk (comb_Non-risk), and from Iso1Risk and
Iso3Risk (comb_Risk) (Additional file 6: Table S6 showing
the DEGs and the results of gene enrichment analysis for
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Fig. 2 Expression profiling of the CCHCR1-HEK293 cell lines highlighted cell adhesion and actin cytoskeleton. a Heatmaps showing gene
expression of focal adhesion and regulation of actin cytoskeleton in the CCHCR1 Iso1Non-risk (1 N), Iso1Risk (1R), Iso3Non-risk (3 N), and
Iso3Risk (3R) cell lines, and in the vector transfected cells (V), and wild type HEK293 (WT). Color key: red represents upregulated and blue
downregulated expression (row Z-score). b The expression of FN1, TLN1, and SYT1 in the CCHCR1-HEK293 cell lines was validated with
qPCR, and compared with the gene expression in the wild type cells. Error bars: standard deviation. Here shown normalization
with HPRT1
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Fig. 3 Gene expression profiles of Wnt and RIG-I-like signaling in the CCHCR1-HEK293 cell lines. Both pathways were highlighted in the CCHCR1
cell lines. Heatmaps of Wnt (a) and RIG-I-like (RLR) (b) signaling in the Iso1Non-risk (IN), Iso1Risk (1R), Iso3Non-risk (3 N), and Iso3Risk (3R) CCHCR1
cell lines, vector transfected cells (v), and wild type HEK293 (wt) demonstrated that there were differences between cell lines. Wnt signaling is
mainly upregulated only in the Iso3Non-risk cells while RLR signaling shows more downregulation in Iso3Risk than in other cell lines. Color key:
red represents upregulated and blue downregulated expression (row Z-score). c The expression of CXCL8 in the CCHCR1-HEK293 cell lines was
validated with qPCR, and compared with the gene expression in the wild type cells. Here shown normalization with HPRT1. Error bars:
standard deviation
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comb_Non-risk and comb_Risk), although the haplotypes
showed less clustering than the isoforms. To control the
specificity of the results we also generated mock gene lists
by permuting the sample groupings in the comparison
(Additional file 6: Table S6 showing the summary of gene
enrichment analyses of the mock gene lists). Several path-
ways were highlighted among the most mock gene lists.
There were, however, pathways that were highlighted spe-
cifically among the CCHCR1-HEK293 clones; adherens
junction and tight junction in comb_Iso1, and RNA trans-
port and mRNA surveillance in comb_Iso3 (FDR < 0.002)
and comb_Non-Risk (FDR = 0.01) (Additional file 5: Table
S5; Additional file 6: Table S6), which agreed the results
obtained with the cell line specific DEGs (Additional file
3: Table S3). RIG-I-like receptor signaling, which was
highlighted in the pathway analyses of individual CCHCR1
clones (Additional file 3: Table S3), rose up in comb_Iso1
(FDR = 0.06) as well. Progesterone mediated oocyte mat-
uration was highlighted in comb_Iso3 (FDR = 0.01) as was
also detected in the analysis of the shared Iso3 DEGs
(Additional file 4: Table S4; Additional file 5: Table S5).
Mitochondria that play a role in the sythesisof steroids
was highlighted among the comb_Iso3 DEGs as well. Sev-
eral HLA genes were overrepresented especially in com-
b_Iso3, highlighting pathways such as systemic lupus
erythematosus (FDR = 0.0002) and antigen processing and
presentation (FDR = 0.02). The latter and HLA-genes were
highlighted also in the pathways analysis of comb_Risk
which otherwise showed much less overrepresented path-
ways than the other groups.
Gene expression in the CCHCR1-HEK293 cell lines and
psoriatic skin
The comparison of transcriptomes from two completely dif-
ferent biological systems, such as the CCHCR1-HEK293 cell
lines and psoriatic skin, is challenging and the direct com-
parison of gene expression changes is unfeasible. Some simi-
larities were observable when the current expression results
of CCHCR1 cells were compared to our previous RNAseq
data on psoriatic skin obtained from the comparison be-
tween psoriatic lesional and non-sessional skin, and healthy
control skin [20]. The comparison revealed some similarities
in the gene expression changes, such as upregulation of S100
and KRT (KRT6, KRT16, and KRT17) genes, and enrichment
of the steroid-related pathways. Some genes of RIG-I-like re-
ceptor signaling (DDX58, CXCL8, and CASP8) showed al-
tered expression in the CCHCR1-HEK293 cells and psoriatic
skin, as well. The results, however, should not be over inter-
preted, as psoriasis is a complex disease and CCHCR1 is a
susceptibility gene among several others, and as mentioned
the direct comparison of CCHCR1 cells and skin samples is
not warranted.
Fig. 4 Isoform- and haplotype-specific differences between the CCHCR1-HEK293 cell lines. The Venn diagram of the DEGs (FC > 1.5 or < 0.75, FDR
< 0.25) from the CCHCR1-HEK293 cell lines Iso1Non-risk (1 N), Iso1Risk (1R), Iso3Non-risk (3 N), and Iso3Risk (3R) when compared with the control
cells, and the DEGs from the psoriatic skin samples (Ps) [20]. The most highlighted gene enrichment pathways of DEGs (both the up- and down-
regulated) that were shared by the Non-risk, Risk, Iso1, Iso3, or all the CCHCR1 cell lines are shown. The DEGs used for the gene enrichment
analysis are shown in parentheses and indicated by color coded rectangles in the diagram. The DEGs (diff) and the results are shown in detail in
the Additional file 4: Supplement Table S4
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We also examined the CCHCR1 genotype (*Iso1 or
*Iso3, *Non-risk or *Risk allele) and the most well-known
psoriasis haplotype HLA-Cw*06:02 in our psoriatic and
healthy skin samples. The genotyping results are shown
in detail in Additional file 7: Table S7. We genotyped the
SNPs for rs3130453 (G/A) resulting *Iso1 or *Iso3 allele
and rs130076 (C/T) corresponding to the second R/W
amino acid change in CCHCR1*WWCC risk allele. Five
out of seven psoriatic samples were homozygous for the
*Iso3 allele, whereas only two out of eight were homozy-
gous in the controls. None of the psoriatic samples had
the homozygous *Iso1 genotype. Only two of the
psoriatic patients were heterozygous and therefore
able to translate the longer isoform 1 as well. Five
out of seven psoriatic samples were heterozygous for
the Risk (*WWCC) haplotype whereas five out of
eight controls had the homozygous Non-risk haplo-
type. Most of the control samples were negative for
the psoriasis haplotype HLA-Cw*06:02 (six out of
eight) but most of the psoriasis samples were hetero-
zygous positive (five out of seven). The genotyping of
psoriatic samples agrees the previous results [20], but
the number of samples didn’t allow studying the cor-
relation of CCHCR1 genotype and gene expression
profiles. The systematic identification of all potentially
causal variants in psoriasis in order to study the ef-
fects of individual variants or their combinations
would be an extremely laborious task to implement
in practice. The CCHCR1 and HLA-Cw6 genotypes
were illustrated in a PCA plot that clusters the sam-
ple types (Additional file 7: Figure S2).
CCHCR1 affects P-body-related functions and shows
isoform-specific localization with P-bodies
The recent study [15] that localized CCHCR1 at
P-bodies was carried out with the Iso3Non-risk form of
CCHCR1. Interestingly in our RNAseq data, the
P-body-related pathways RNA transport, RNA degradation,
and mRNA surveillance were highlighted in the Iso3 cells
(WebGestalt p < 1 × 10− 15) and especially in the Non-risk
cells (FDR < 0.1) (Additional file 5: Table S5; Additional
file 6: Table S6). Also the comparison Iso3Non-risk cells
versus controls revealed the enrichment of mRNA surveil-
lance (FDR = 1.7 × 10− 9) (Additional file 3: Table S3: the
gene enrichment results of 3 N); several SMG genes
(e.g. SMG1, SMG5, and SMG7) that code nonsense
mediated mRNA decay factors of surveillance com-
plex [25], and CPSF genes encoding cleavage and
polyadenylation specific factors were upregulated (1.5
< FC < 2.5). Heatmap of mRNA surveillance gene
expression in the CCHCR1-HEK293 cell lines is
shown in Fig. 5a. Although the gene expression
changes were moderate, more than half of the genes
acting in the mRNA surveillance pathway showed
altered expression in Iso3Non-risk (the KEGG pathway of
mRNA surveillance is shown in detail in Additional file 3:
Table S3: mRNA surveillance).
Here, we studied by immunofluorescence staining with
the P-body markers EDC4 and DCP1A (Fig. 5b, c) [15]
and the centrosomal marker γ-tubulin (Additional file 8:
Supplementary information Figure S2) whether the dif-
ferent CCHCR1 isoforms localize with the P-bodies in
the same manner. We observed differences in the stain-
ing pattern between the isoforms; in the Iso1 cells, espe-
cially in Iso1Non-risk, the P-body marker colocalized
rarely with CCHCR1, whereas in the Iso3 cells the
P-body staining colocalized with the CCHCR1 granules
(P < 4 × 10− 19) (Additional file 8: Supplementary infor-
mation describes the counting of colocalization of
CCHCR1 and P-body markers). In addition, we demon-
strated by γ-tubulin staining that in the Iso1 cells
P-body markers showed less accumulation at the centro-
somes (Additional file 8: Figure S2).
Discussion
Our results show the power of RNAseq providing a large
amount of detailed expression data on the HEK293 cells
expressing the CCHCR1 variants. The principal compo-
nent and gene enrichment analyses demonstrated that
the cell lines expressing different isoforms and haplo-
types of CCHCR1 have their distinct, specific expression
profiles. The approach also strengthened the previous
findings of the putative roles of CCHCR1 in the
regulation of cytoskeleton (Fig. 6) and steroid biosyn-
thesis [6, 8]. Additionally, the RNAseq revealed that
CCHCR1 affected the cell signaling pathways mediated
via the P-bodies, which provided evidence of its possible
active role at the P-bodies. Furthermore, we observed
isoform- and haplotype-specific differences in its effects
on the P-body-related functions, as well as on the
localization with the P-bodies. The P-body localization
may also explain some of the putative interactions of
CCHCR1 that have been previously identified with such
proteins as StAR, RPB3, and viral proteins (Fig. 6) [11,
12, 26]. We also compared the gene expression results
of the CCHCR1-HEK293 cell lines and psoriatic skin,
though the direct comparison of transcriptomes of two
completely different biological sample types is unfeasible.
The approach was unable to give any final direct
answers to the question what is the putative role of dif-
ferent CCHCR1 variants. As an adenovirus-transformed
cell line HEK293 cells have gone through structural al-
terations of genome. Therefore it is possible that we
have missed some gene expression data of the CCHCR1
cell lines. Furthermore the tumorigenic properties of
HEK293 may have affected the gene regulation and -ex-
pression of the cell lines.
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Fig. 5 CCHCR1 shows isoform-specific localization with centrosomal P-bodies and affects mRNA surveillance pathway. a Heatmap showing gene
expression profiles of mRNA surveillance pathway in Iso1Non-risk (1 N), Iso1Risk (1R), Iso3Non-risk (3 N), and Iso3Risk (3R) CCHCR1-HEK293 cell
lines, and in control cells; vector (V) and wildtype (WT). Color key: red represents upregulated and blue downregulated expression (row Z-score).
b Immunofluorescent staining of the CCHCR1 (red) cell lines: Iso1Non-risk, Iso1Risk, Iso3Non-risk, and Iso3Risk, with the P-body markers (green)
EDC4 and DCP1A. Panel b shows the overlap of red and green, and panel c shows the green channel images of the corresponding sites. The
colocalization (orange) of CCHCR1 and P-body markers is absent in the Iso1Non-risk and Iso1Risk cells: only the CCHCR1 expression (red) is
observable at the centrosomes and cytoplasm (b), whereas the antibodies against EDC4 and DCP1A fail to recognize these structures (c). In
Iso3Non-risk and Iso3Risk, the colocalization (orange, marked with arrow heads in panel b) is observable with antibodies against the EDC4 and
DCP1A (green in panel c). Nuclei are stained with DAPI (blue). Scale bar: 10 μm
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CCHCR1 affects the expression of several genes
regulating cytoskeleton and cell-cell adhesion
Tight junction and adherens junction, were highlighted
especially in the Iso1 cells and showed gene enrichment in
the Iso3 cells as well. Interestingly we have recently observed
CCHCR1 expression in the skin in the proximity of the cell
membrane and desmosomes [6] that are like the tight and
adherens junctions specialized for cell-cell adhesion. The re-
lated functions; regulation of actin cytoskeleton and focal
adhesion, were also highlighted in the CCHCR1-HEK293 cell
lines. They also showed enrichment among the mock genes.
These two pathways consist of a large number of genes,
hence their highlightment may result from several different
gene combinations and expression changes (up versus
Fig. 6 Model for CCHCR1 action in a cell and skin. CCHCR1 is expressed in a basal layer of keratinocytes in the epidermis of the healthy skin. In the
thickened psoriatic epidermis, it is expressed in supra-basal layers as well. It is a dynamic protein that might play a role both in the cytoplasm at the
centrosomes and P-bodies that occasionally colocalize, and possibly in the nucleus as well. Both centrosomes and P-bodies are physically linked to the
cytoskeleton (cytokeratin (CK), actin, and microtubules (black lines)) that functions as a scaffold for the regulation of e.g. cell division and adhesion,
mRNA transport and turnover, and transport of organelles like mitochondria. The previous results and the present RNAseq suggested that CCHCR1
regulates expression of cytoskeletal components and functions related to cytoskeleton, such as cell adhesion [6]. Furthermore, CCHCR1 may control
the mRNA surveillance via the P-bodies, which may affect a wide variety of biological processes. Previous studies have identified several interaction
partners for CCHCR1, these including the mitochondrial StAR protein that regulates steroidogenesis [8, 11], the RNA polymerase II subunit 3 (RPB3) that
regulates transcription [12], some mitotic spindle proteins [15], and several viral proteins [30]. These interactions may result from the P-body
localization of CCHCR1, or from the dynamic nature of CCHCR1 and its ability to regulate various processes via cytoskeleton. RNAseq identified several
pathways for CCHCR1 which are relevant for the pathogenesis of psoriatic epidermis, epidermis development, and innate immunity. Interestingly, also
the innate immunity including the RIG-like receptor (RLR) signaling is affected by the P-bodies
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down). Actin cytoskeleton and focal adhesion share several
genes with adherens and tight junctions that were not
highlighted among the mock genes. Furthermore, the func-
tions related to the cytoskeleton are supported by our previ-
ous microscopic observation; the actin cytoskeleton of the
Iso1 cells resembled that of wild type cells, but was disturbed
in the Iso3 cells. Furthermore, after disruption of microtu-
bules, the Iso3Risk cells, especially, showed aberrant actin
organization [6]. Here, we showed that several relevant
genes, including TLN1 (talin 1), FN1 (fibronectin 1), and
FLNC (filamin C), were downregulated in the Iso3Risk cells,
which may disturb cytoskeleton organization. Talin
plays a role in the assembly of actin filaments and in-
teracts indirectly with extracellular fibronectin 1 [27],
and they both play a role in adhesion, spreading, and
migration of cells [28, 29]. Filamin crosslinks actin fil-
aments into networks and anchor membrane proteins
to the cytoskeleton, thereby affecting cell-cell and
focal adhesion. Our previous results, as well as RNA-
seq, also highlighted other cytoskeleton-related genes;
several cytokeratin genes, e.g. KRT17 were upregu-
lated especially in the Iso1Non-risk cells [6]. One of
the most highly upregulated genes in the Iso3 cells was
SYT1. It encodes for synaptotagmin that interacts with
tubulin, and may act as a microtubule-organizing
center-associated protein, thus playing a role in spindle
organization [30, 31].
CCHCR1 shows isoform-specific effects on P-body
localization and P-body-related functions
We have shown that in cultured cells CCHCR1 isoforms
1 and 3 reside in the cytoplasm, as well as localize at the
centrosomes [6, 8]. Interestingly, here we noticed a dif-
ference in their colocalization with the P-bodies in the
HEK293 cells. The immunostaining supported colocali-
zation with the P-bodies for isoform 3, especially at the
centrosome, while isoform 1 colocalized rarely with the
P-bodies. The localization of P-bodies at the centro-
somes seemed to be improved by the overexpression of
Iso3 CCHCR1. Recently it was shown that the
N-terminus of Iso3Non-risk was necessary for the
P-body localization [15], isoform 1 that is 89 amino acids
longer at its N-terminus than Isoform 3 was not along
in this study. The different N-terminus may explain the
localization difference between isoforms 1 and 3.
Previous studies have shown that there is a strong inter-
action between CCHCR1 and EDC4 (enhancer of
mRNA-decapping 4 protein) [15] that is a central P-body
component regulating mRNA decay by decapping and
5′→ 3′ mRNA degradation. In our RNAseq, mRNA sur-
veillance pathway that is detecting and degrading abnor-
mal mRNAs [32, 33] was highlighted in the HEK293 cells
expressing Iso3Non-risk, the same isoform that was used
in the previous binding studies. In addition to mRNA
surveillance, the pathway analyses of the pooled data of
Non-risk and Iso3 highlighted RNA degradation and RNA
transport. mRNA surveillance includes nonsense-mediated
mRNA decay (NMD) that eliminates mRNAs containing
premature translation-termination codons [33]. In the
RNAseq, several SMG genes encoding factors of NMD
surveillance complex, and CPSF genes encoding for cleav-
age and polyadenylation specific factors, were upregulated
in Iso3Non-risk.
P-bodies have been associated with several auto-
immune diseases, cancers, and neurological diseases
[34, 35], but not with psoriasis. They are linked to vi-
ruses and innate immunity as well. The P-bodies are
manipulated by the viruses for a productive infection
to occur, but they also promote immune responses to
the viral infection, e.g., via double-stranded RNA pro-
tein kinase (PKR alias EIF2AK2) [36]. Viruses, such as
human papillomavirus HPV16 E6, induce in keratino-
cytes the localization of PKR into the P-bodies sug-
gesting about the antiviral response. Interestingly, the
interaction of CCHCR1 with HPV16 E2 induced a
massive redistribution of the virus protein into cyto-
plasmic granules that were still co-localizing with
CCHCR1 [30]. We suggest that these structures were
cytoplasmic P-bodies playing an antiviral role. Inter-
estingly, RIG-I-like receptor signaling, which was
highlighted both in the CCHCR1-HEK293 cell lines
and psoriatic skin, is part of the antiviral immune re-
sponse. The function of RIG-I-like receptors is linked
at many levels to different RNA-granules including
P-bodies [37].
Conclusions
The RNAseq highlighted pathways that support an ac-
tive role for CCHCR1 in the centrosomes and P-bodies;
the most significant pathways were related to the
cytoskeleton and cell adhesion, and furthermore, the
mRNA surveillance pathway was highlighted in the
Iso3Non-risk cells. The centrosomes and P-bodies are
physically linked to the cytoskeleton that functions as a
scaffold for the P-bodies (Fig. 6) and transported
mRNAs [17, 18], thus as a centrosomal P-body protein
CCHCR1 might affect diverse cytoskeleton mediated
processes, such as cell division, cell adhesion, and trans-
port of mRNA and mitochondria. The RNAseq revealed
clear isoform- and some haplotype-specific differences;
the Iso1 and Iso3 cells showed specific clustering as two
separate groups, and the Non-risk and Risk cells often
exhibited opposite effects. Putative effects arising from
the tumorigenic nature of HEK293 can’t be completely
ruled out. In summary, the present study strengthened
the previous observations about the effects and possible
interaction partners of CCHCR1 in the cell, as well as
provided new clues about its possible function.
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Methods
Samples, RNA extraction, and RNAseq
Generation of stable cell lines overexpressing the dif-
ferent CCHCR1 isoforms was described in our previ-
ous study [6]. Briefly, CCHCR1-pDsRed-constructs
(Iso1Non-risk, Iso1Risk, Iso3Non-risk, or Iso3Risk) or
vector were stably transfected into HEK293 which is
an easily transfectable tumorigenic cell line. Colonies
resistant to G418 antibiotics were screened for the
CCHCR1 expression by qPCR and fluorescence mi-
croscopy. The expression of selected clones was veri-
fied by Western blotting [6]. The RNA extraction was
performed at the same time as the quantification of
clones without further passaging of cell lines. For the
microarray and RNAseq experiments the total RNA
of the CCHCR1 cell lines and controls was extracted
by a RNeasy kit (Qiagen) and RNA quality was con-
trolled by Bioanalyzer (RIN for all samples > 8.5).
Total RNA samples, three replicates for each
CCHCR1-HEK293 cell line were used for the RNAseq
library preparation according to the previous
single-cell tagged reverse transcription (STRT) proto-
col [38], which was adjusted for 10 ng samples as in
our previous studies [20, 24]. The libraries were se-
quenced using an Illumina HiSeq 2000 instrument.
Pre-processing of STRT reads, alignments and
per-gene quantitation were performed as previously
described [38]. The data normalization and differential ex-
pression analyses were performed using SAMstrt [39]
(https://github.com/shka/R-SAMstrt/wiki), which is an
enhancement of SAMseq [PMID: 22127579] for the spi-
kein-base normalization. Differentially expressed genes
were extracted by two class unpaired comparison;
threshold of the significantly regulated genes was
FDR < 1%. We performed PCA with the scaling but
non-centering pre-process steps. A higher permuta-
tion (n = 1000) was applied to the comparisons with
pooled samples (comb_Iso1, -Iso3, −Risk, and –Non-risk).
The mock analysis with permutated sample groups was
performed to find possible false positive pathway results
and included six manual permutations per comparison
group.
The RNAseq of psoriatic skin samples was recently
outlined elsewhere [20]. Briefly, all subjects involved in
this study gave written informed consent and the study
followed the Declaration of Helsinki Guidelines. The
Institutional Review Board of the Helsinki University
Central Hospital had approved the study and the collec-
tion of skin samples. The skin samples were harvested
by a compressed air-driven dermatome (Zimmer®,
Warsaw, IN) to obtain an epidermal sample with min-
imal dermis involvement. We collected lesional (PL) and
non-lesional (PN) samples from six psoriatic patients
and normal healthy skin from nine controls (C).
Microarray study with isoform 1-overexpressing cells
For the microarray study we used GeneChip® Human
Gene 1.0 ST Arrays. The total RNA samples of cells
were hybridized according to manufacturer’s protocols
(Affymetrix Inc., Santa Clara, CA, USA). The arrays
were scanned with GeneChip scanner 3000 7G (Affyme-
trix Inc.). The analyses of the microarray data were per-
formed using the statistical software R (http://
www.R-project.org) using the Affy and Limma packages
[40, 41] similar to procedure earlier described [42]. In
short, we implemented the robust multiarray average
method (RMA) [43] to normalize and calculate the Log2
expression values at gene level (annotated using hugen-
e10stv1.r3cdf_2.5.0). We did pair-wise comparison con-
trasts between the vector control and the different
CCHCR1-HEK293 cell lines followed with t-statistics
and log-odds of differential expression (B-value). The
original microarray data compliance with MIAME pro-
cedure has been submitted to ArrayExpress (the acces-
sion number E-MTAB-6848).
Quantitative real-time PCR
We used qPCR to validate the expression of AREG, FN1,
TLN1, CXCL8, and SYT1 genes in the CCHCR1-HEK293
cell lines. cDNA synthesis was carried out with random
primers and SuperScript III First-Strand synthesis system
(Invitrogen) according to manufacturer’s instructions.
qPCR was carried out using an ABI PRISM 7900HT Se-
quence Detection System with pre-designed TaqMan®
Gene Expression Assays (Thermo Fisher Scientific) or
with self-designed primers by using Fast SYBR® Green
Master mix (Thermo Fisher Scientific) for detection, ac-
cording to manufacturer’s instructions. Lists of
pre-designed TaqMan Gene Expression Assays and nu-
cleotide sequences of self-designed qPCR primers are
shown in Additional file 8. Each sample was run in three
replicates and the experiments were run twice. HPRT1
was used as a reference gene for normalization and the
samples were compared against the wild type HEK293
sample. Statistical comparisons were made with the Stu-
dent’s t-test.
SNP genotyping
We genotyped the CCHCR1 SNPs rs3130453 (CCH
CR1*Iso1/3) and rs130076 (CCHCR1*WWCC/RRGS)
with commercial allelic discrimination assays with
pre-designed probes and primers (TaqMan) described
previously [6] from DNA extracted from the skin sam-
ples [20]. Sample C.05 was not genotyped due to lack of
sufficient amount of sample for DNA extraction. The
HLA-Cw*06:02 genotype was also determined with com-
mercial allelic discrimination assays (TaqMan) [44].
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Immunofluorescence
The CCHCR1-HEK293 cell lines, vector control, and
wild type HEK293 cells were grown on cover slips
coated with rat tail collagen I (Gibco, Invitrogen) and
fixed with 4% paraformaldehyde solution. After fixation
cells were permeabilized with 0.1% Triton-×100 in PBS.
The samples were incubated 1 h at room temperature
with the antibodies against P-body markers EDC4
(rabbit polyclonal, Cell Signaling) and DCP1A (mouse
monoclonal, Abnova), and centrosome marker γ-tubulin
(mouse monoclonal, Sigma). Alexa Fluor 555 and 488
conjugated IgGs (Invitrogen, Molecular Probes) were
used as secondary antibodies and the nuclei stained with
DAPI (4′,6-diamidino-2-phenylindole, Sigma-Aldrich).
The pictures were taken with Zeiss LSM 5 Duo confocal
microscope. Differences in localization of CCHCR1 iso-
forms with centrosomal P-bodies were determined by
counting colocalized staining of CCHCR1 and EDC4
and DCP1A in each CCHCR1-overexpressing cell line
blindly (Additional file 8: Supplementary Information
about qPCR and co-localization of CCHCR1 with
P-body markers).
Additional files
Additional file 1: Table S1. Microarray data and gene enrichment
analysis of the CCHCR1 Iso1 cell lines. Gene expression profiling data of
microarrays from the Isoform 1 CCHCR1-HEK293 cell lines. Gene enrich-
ment analysis of differentially expressed genes using the KEGG pathway
analysis of WebGestaltR and functional cluster analysis of the DAVID.
(XLSX 305 kb)
Additional file 2: Table S2. Differentially expressed genes of RNAseq
from the comparisons between the CCHCR1-HEK293 cell lines and con-
trols. Up- and downregulated DEGs of CCHCR1-overexpressing cell lines
Iso1Non-risk (1 N), Iso1Risk (1R), Iso3Non-risk (3 N), and Iso3Risk (3R) when
compared with controls (wild type and vector transfected cells). (XLSX
1215 kb)
Additional file 3: Table S3. Gene enrichment analysis of DEGs from the
CCHCR1-HEK293 cell lines based on RNAseq. Cell line-specific gene en-
richment analyses of DEGs (Additional file 2: Table S2) from the CCHCR1-
overexpressing cell lines Iso1Non-risk (1 N), Iso1Risk (1R), Iso3Non-risk
(3 N), and Iso3Risk (3R) when compared with wild type and vector con-
trols. The gene enrichment analysis of DEGs that were shared by the four
CCHCR1 cell lines (Intersection). Analyses were done using the KEGG
pathway analysis (WebGestaltR and WebGestalt), and GO and cluster ana-
lyses from DAVID. Gene enrichment of Iso3Non-Risk DEGs in the mRNA
surveillance pathway is shown (KEGG pathway figure and a list of genes).
(XLSX 1183 kb)
Additional file 4: Table S4. Isoform- and haplotype-specific gene en-
richment with the shared DEGs of the CCHCR1-HEK293 cell lines. Gene
enrichment analyses of DEGs shared by only the Non-risk (Diff N), Risk
(Diff R), isoform 1 (Diff iso1), or isoform 3 (Diff iso3) CCHCR1cell lines (see
in detail Fig. 4 Venn diagram). The DEGs shared by all the CCHCR1 cell
lines (Intersection) were analyzed as well. Analyses were done using the
GO and cluster analyses from DAVID and KEGG pathway analysis from
WebGestalt and WebGestaltR. (XLSX 307 kb)
Additional file 5: Table S5. Isoform specific gene enrichment analyses
based on re-extracted DEGs of the CCHCR1-HEK293 cell lines. The DEGs
were obtained from the pooled data of Iso1Non-risk and Iso1Risk, and
Iso3Non-risk and Iso3Risk compared to the controls (wildtype and vector).
The DEGs (comb_Iso1 and comb_Iso3) were analysed using the KEGG
pathway analysis of WebGestaltR. (XLSX 3054 kb)
Additional file 6: Table S6. Haplotype specific gene enrichment
analyses based on re-extracted DEGs of the CCHCR1-HEK293 cell lines.
The DEGs were obtained from the pooled data of Iso1Non-Risk and
Iso3Non-Risk, and Iso1Risk and Iso3Risk compared to the controls (wild-
type and vector). The DEGs (comb_Non-Risk, comb_Risk) were analysed
using the KEGG pathway analysis of WebGestaltR. Summary of the gene
enrichment results among the mock DEGs lists. (XLSX 2314 kb)
Additional file 7: Table S7 and Figure S1. CCHCR1 and HLA-Cw6 ge-
notypes of the skin samples. Figure S1. The CCHCR1 and HLA-Cw6 ge-
notypes illustrated in a PCA plot. (XLSX 79 kb)
Additional file 8: Supplementary Information and Figure S2.
Information about qPCR and co-localization of CCHCR1 with P-body
markers. Lists of pre-designed TaqMan Gene Expression Assays and
nucleotide sequences of self-designed qPCR primers. Counting the
colocalization of CCHCR1 with P-body markers in the CCHCR1-HEK293
cell lines and calculation of p-values for the comparison between cell lines.
Figure S2. γ-tubulin staining of the CCHCR1 cells. Antibody against
γ-tubulin was used as a marker for centrosomes. (PDF 1046 kb)
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